Published in Drug Law Weekly, June 9th, 2009
"Optimization of the medium flow rate (100mL/min) and perfusion duration (12 h) yielded cell constructs with high cell seeding efficiency (98% of the input cells)...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
Source: Drug Law Weekly (2009-06-09)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.